Synergizing Software and Hardware Capabilities: Driving AI × GMP × Digital Twin to Accelerate the Implementation of Smart Manufacturing in Biopharmaceuticals TherapiAI, an AI-driven pharmaceutical technology company, announced yesterday (the 21st) the official signing of a strategic partnership Memorandum of
Continue Reading
Google and Japan’s Chiral Share the Stage to Co-Envision the Next Decade of Biopharma TherapiAI, a pioneering biotech AI startup, hosted the “AI-Driven Future of Biopharma: From R&D Innovation to Digital Twin” seminar today (7th) at the Taipei Bioinnovation Park.
Continue Reading
TherapiAI, a leading force in AI-driven drug discovery, officially announced today (the 22nd) its strategic expansion into the Japanese market through a formal partnership with Chiral, an emerging Japanese AI scientific computing startup. This collaboration marks a significant milestone in
Continue Reading
Cracking the ‘Black Box’ of Cell Manufacturing for the First Time ! TherapiAI, a leading AI-powered biopharmaceutical innovator, today announced its latest research collaboration with Dr. Kun-Yi Lin, a prominent stem cell expert from Tri-Service General Hospital. The study, recently
Continue Reading
Leading AI pharmaceutical brand TherapiAI is expanding its footprint in Asia! Following a successful entry into the Japanese market, TherapiAI officially launched its strategic expansion into Southeast Asia today (the 24th). The company recently made its regional debut by unveiling
Continue Reading
[Taipei, Feb 23] — TherapiAI, a leader in AI-driven pharmaceuticals, announced today the launch of the world’s first GMP AI Agent specifically engineered for Pharmaceutical CDMOs. The agent features advanced RAG (Retrieval-Augmented Generation) capabilities for global regulations, including FDA and
Continue Reading
Article Categories
Article Categories
Article Categories
Latest Articles
Follow Us
